Study: CBD Oil ‘Highly Promising’ as Treatment for Pediatric Epilepsy

By Paul Armentano, NORML Deputy Director

Cannabis oil.
Cannabis oil.

The administration of cannabis oil extracts high in cannabidiol reduces seizure frequency in children with intractable epilepsy, according to clinical data published online ahead of print in the journal Seizure.

Israeli researchers retrospectively evaluated the effects of CBD oil in a multicenter cohort of 74 patients with intractable epilepsy. Participants in the trial were resistant to conventional epilepsy treatment and were treated with CBD extracts for a period of at least three months. Extracts in the study were provided by a pair of Israeli-licensed growers and were standardized to possess a CBD to THC ratio of 20 to 1.

Read moreStudy: CBD Oil ‘Highly Promising’ as Treatment for Pediatric Epilepsy

Idaho Senate Approves Cannabis Extract Bill

cannabisoil
A syringe containing cannabis oil.

Idaho’s full Senate has voted 22 to 12 to approve Senate Bill 1146 a proposal to legalize the possession and use of low-THC cannabis extracts for the treatment of epilepsy. The Senate also voted to approve the use of Epidiolex, a cannabis-based medicine from the makers of Sativex. The vote on the latter proposal, Senate Bill 1156, was unanimous.

Senate Bill 1146 would allow those with epilepsy who receive a recommendation from a physician to possess and use cannabis extracts – such as tinctures and oils – that have low amounts of THC (tetrahydrocannabinol), and high amounts of CBD (cannabidiol). Unfortunately no legal method of obtaining the medicine was established.

Read moreIdaho Senate Approves Cannabis Extract Bill

BREAKING: FDA Approves Trials for Cannabis-Based Epilepsy Medicine

The U.S. Federal Drug Administration has given unprecedented approval for two separate trials of Epidiolex, a liquid medicine made entirely of cannabis; the substance contains 98% cannafdabidiol, a nonpsychoactive compound found in cannabis – the remaining 2% consist of various trace amounts of other cannabinoids.

The studies will be led by Orrin Devinsky, MD at New York University’s School of Medicine, and Roberta Cilio, MD, PhD, at the University of California.

Each study will involve 25 participants, all children.

Read moreBREAKING: FDA Approves Trials for Cannabis-Based Epilepsy Medicine